Mannkind (MNKD) Gross Margin Growth (1y) (2017 - 2026)

Mannkind (MNKD) Gross Margin Growth (1y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn -352.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -352.00
Dec 31, 2025 -618.00
Sep 30, 2025 -91.00
Jun 30, 2025 172.00
Mar 31, 2025 95.00
Dec 31, 2024 -4,028.00
Sep 30, 2024 2,166.00
Jun 30, 2024 300.00
Mar 31, 2024 785.00
Dec 31, 2023 4,533.00
Sep 30, 2023 1,503.00
Jun 30, 2023 7,324.00
Mar 31, 2023 9,253.00
Dec 31, 2022 25,229.00
Sep 30, 2022 -2,409.00
Jun 30, 2022 -6,504.00
Mar 31, 2022 -8,139.00
Dec 31, 2021 -13,926.00
Sep 30, 2021 623.00
Jun 30, 2021 181,955.00